Structure Therapeutics Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Structure Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $104.59. The average 1-year stock price forecast is 134.98% higher than the current stock price, while the lowest is $69.5 (+56.14%) and the highest is $145 (+225.77%).

Price Target: $104.59 (+134.98%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$69.5	$104.59	$101	$145
Change	+56.14%	+134.98%	+126.92%	+225.77%

Analyst Ratings

The average analyst rating for Structure Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	11	11	11	12	11	11
Buy	4	4	4	4	4	4
Hold	0	0	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	16	17	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ananda Ghosh H.C. Wainwright	H.C. Wainwright	Buy Reiterates $100 → $70	Buy	Reiterates	$100 → $70	+57.27%	Jun 11, 2026
Hardik Parikh J.P. Morgan	J.P. Morgan	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 9, 2026
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $101	Buy	Maintains	$101	+126.92%	Jun 8, 2026
Andy Hsieh William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Jun 8, 2026
Evan Seigerman BMO Capital	BMO Capital	Buy Maintains $145	Buy	Maintains	$145	+225.77%	Jun 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

38.46M

Revenue Next Year

41.67K

from 38.46M

-99.89%

from 38.46M

EPS This Year

-1.29

from -1.42

EPS Next Year

-1.90

from -1.29

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	38.46M
Operating Income	-37.70M	-52.56M	-102.78M	-158.23M	-186.81M	-393.85M
Net Income	-38.05M	-51.32M	-89.62M	-122.53M	-141.20M	-284.82M
EPS	-	-	-	-	-1.42	-1.29
Free Cash Flow	-18.79M	-26.08M	-51.38M	-70.78M	-180.03M	-350.38M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	500.0M
Avg	38.5M
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-98.7%
Avg	-99.9%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	1.25
Avg	-1.29
Low	-1.93

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-